0000899243-21-033151.txt : 20210816
0000899243-21-033151.hdr.sgml : 20210816
20210816190041
ACCESSION NUMBER: 0000899243-21-033151
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210812
FILED AS OF DATE: 20210816
DATE AS OF CHANGE: 20210816
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Huang Alan
CENTRAL INDEX KEY: 0001877364
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39485
FILM NUMBER: 211180418
MAIL ADDRESS:
STREET 1: TANGO THERAPEUTICS, INC.
STREET 2: 100 BINNEY STREET, UNIT 700
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Tango Therapeutics, Inc.
CENTRAL INDEX KEY: 0001819133
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 100 BINNEY ST
STREET 2: SUITE 700
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: (857) 320-4900
MAIL ADDRESS:
STREET 1: 100 BINNEY ST
STREET 2: SUITE 700
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: BCTG Acquisition Corp.
DATE OF NAME CHANGE: 20200723
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-08-12
0
0001819133
Tango Therapeutics, Inc.
TNGX
0001877364
Huang Alan
C/O TANGO THERAPEUTICS, INC.
100 BINNEY STREET, SUITE 700
CAMBRIDGE
MA
02142
0
1
0
0
Chief Scientific Officer
Stock Option (Right to Buy)
9.56
2021-08-12
4
A
0
169859
0.00
A
2031-08-12
Common Stock
169859
169859
D
This option shall vest and become exercisable over a four-year period, at a rate of 25% on August 10, 2022, with the remaining option shares vesting in 36 equal monthly installments thereafter.
/s/ William Collins, as attorney-in-fact
2021-08-16